Baidu
map

Circulation:CABG和PCI治疗血管病变或左心室收缩功能不全,孰优孰劣?

2016-05-13 fsy 译 MedSci原创

指南建议冠状动脉旁路移植术(CABG)对治疗多支血管病变和严重左心室(LV)收缩功能不全优于经皮冠状动脉介入治疗(PCI)。然而,在此类患者的随机试验中,还没有对CABG和PCI进行比较。该研究纳入了多支血管病变和LV收缩功能不全(射血分数≤35%)的患者,这些患者接受过依维莫司洗脱支架带(EES)的PCI或CABG,这些患者是从纽约州的注册中挑选出来的。主要成果是长期的全因死亡。次要终点为心肌梗

指南建议冠状动脉旁路移植术(CABG)对治疗多支血管病变和严重左心室(LV)收缩功能不全优于经皮冠状动脉介入治疗(PCI)。然而,在此类患者的随机试验中,还没有对CABG和PCI进行比较。

该研究纳入了多支血管病变和LV收缩功能不全(射血分数≤35%)的患者,这些患者接受过依维莫司洗脱支架(EES)的PCI或CABG,这些患者是从纽约州的注册中挑选出来的。主要成果是长期的全因死亡。次要终点为心肌梗死、卒中和再次血运重建的个别结果。在满足该研究纳入标准的4616名患者中(1351例EES和3265例CABG),倾向评分匹配确定了2126例有相似倾向性分数的患者。在短期内,与CABG相比,PCI可降低卒中的风险[HR=0.05; 95%CI为0.01至0.39; P=0.004]。在长期随访(平均2.9年)过程中,PCI治疗有类似的死亡风险(HR=1.01; 95%CI 0.81-1.28; P=0.91),增加了心肌梗死的风险(HR=2.16; 95%CI 1.42-3.28; P=0.0003),降低了卒中的风险(HR=0.57; 95%CI 0.33-0.97; P=0.04),并且再次血运重建的风险更高(HR=2.54; 95%CI 1.88-3.44; P<0.0001)。对于血运重建的完整性,交互检验具有统计学意义(P=0.002),例如在通过PCI实现完全血运重建的患者中,在PCI和CABG之间,心肌梗死没有区别。

在多支血管病变和严重左室收缩功能不全的患者中,与CABG相比,EES PCI具有类似的长期生存率。PCI增加了心肌梗死(在那些不完全血运重建的患者中)和再次血运重建的风险,而CABG增加了卒中的风险。

原始出处:


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2030087, encodeId=c67a203008e43, content=<a href='/topic/show?id=a96d13850d7' target=_blank style='color:#2F92EE;'>#PCI治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13850, encryptionId=a96d13850d7, topicName=PCI治疗)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKUdkK5dVTue7YQDvwqM1ugOuEpDZEzvXhoGClFiavehcrNAYDuPbks3MkKLPpyAEicgic80KguxwicYQ/132, createdBy=ec952500165, createdName=ms5187542471278033, createdTime=Fri Jan 06 23:13:00 CST 2017, time=2017-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1644476, encodeId=6d0d16444e632, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Sat Sep 17 23:13:00 CST 2016, time=2016-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1391054, encodeId=d81e139105434, content=<a href='/topic/show?id=6d0689e19f0' target=_blank style='color:#2F92EE;'>#血管病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89719, encryptionId=6d0689e19f0, topicName=血管病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Sun May 15 05:13:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413167, encodeId=dbb7141316ea8, content=<a href='/topic/show?id=1d7e48033f5' target=_blank style='color:#2F92EE;'>#左心室#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48033, encryptionId=1d7e48033f5, topicName=左心室)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15012955474, createdName=wushaoling, createdTime=Sun May 15 05:13:00 CST 2016, time=2016-05-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2030087, encodeId=c67a203008e43, content=<a href='/topic/show?id=a96d13850d7' target=_blank style='color:#2F92EE;'>#PCI治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13850, encryptionId=a96d13850d7, topicName=PCI治疗)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKUdkK5dVTue7YQDvwqM1ugOuEpDZEzvXhoGClFiavehcrNAYDuPbks3MkKLPpyAEicgic80KguxwicYQ/132, createdBy=ec952500165, createdName=ms5187542471278033, createdTime=Fri Jan 06 23:13:00 CST 2017, time=2017-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1644476, encodeId=6d0d16444e632, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Sat Sep 17 23:13:00 CST 2016, time=2016-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1391054, encodeId=d81e139105434, content=<a href='/topic/show?id=6d0689e19f0' target=_blank style='color:#2F92EE;'>#血管病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89719, encryptionId=6d0689e19f0, topicName=血管病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Sun May 15 05:13:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413167, encodeId=dbb7141316ea8, content=<a href='/topic/show?id=1d7e48033f5' target=_blank style='color:#2F92EE;'>#左心室#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48033, encryptionId=1d7e48033f5, topicName=左心室)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15012955474, createdName=wushaoling, createdTime=Sun May 15 05:13:00 CST 2016, time=2016-05-15, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2030087, encodeId=c67a203008e43, content=<a href='/topic/show?id=a96d13850d7' target=_blank style='color:#2F92EE;'>#PCI治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13850, encryptionId=a96d13850d7, topicName=PCI治疗)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKUdkK5dVTue7YQDvwqM1ugOuEpDZEzvXhoGClFiavehcrNAYDuPbks3MkKLPpyAEicgic80KguxwicYQ/132, createdBy=ec952500165, createdName=ms5187542471278033, createdTime=Fri Jan 06 23:13:00 CST 2017, time=2017-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1644476, encodeId=6d0d16444e632, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Sat Sep 17 23:13:00 CST 2016, time=2016-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1391054, encodeId=d81e139105434, content=<a href='/topic/show?id=6d0689e19f0' target=_blank style='color:#2F92EE;'>#血管病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89719, encryptionId=6d0689e19f0, topicName=血管病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Sun May 15 05:13:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413167, encodeId=dbb7141316ea8, content=<a href='/topic/show?id=1d7e48033f5' target=_blank style='color:#2F92EE;'>#左心室#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48033, encryptionId=1d7e48033f5, topicName=左心室)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15012955474, createdName=wushaoling, createdTime=Sun May 15 05:13:00 CST 2016, time=2016-05-15, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2030087, encodeId=c67a203008e43, content=<a href='/topic/show?id=a96d13850d7' target=_blank style='color:#2F92EE;'>#PCI治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13850, encryptionId=a96d13850d7, topicName=PCI治疗)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKUdkK5dVTue7YQDvwqM1ugOuEpDZEzvXhoGClFiavehcrNAYDuPbks3MkKLPpyAEicgic80KguxwicYQ/132, createdBy=ec952500165, createdName=ms5187542471278033, createdTime=Fri Jan 06 23:13:00 CST 2017, time=2017-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1644476, encodeId=6d0d16444e632, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Sat Sep 17 23:13:00 CST 2016, time=2016-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1391054, encodeId=d81e139105434, content=<a href='/topic/show?id=6d0689e19f0' target=_blank style='color:#2F92EE;'>#血管病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89719, encryptionId=6d0689e19f0, topicName=血管病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Sun May 15 05:13:00 CST 2016, time=2016-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413167, encodeId=dbb7141316ea8, content=<a href='/topic/show?id=1d7e48033f5' target=_blank style='color:#2F92EE;'>#左心室#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48033, encryptionId=1d7e48033f5, topicName=左心室)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15012955474, createdName=wushaoling, createdTime=Sun May 15 05:13:00 CST 2016, time=2016-05-15, status=1, ipAttribution=)]

相关资讯

NEJM:远程缺血预处理不能改善CABG手术的临床疗效

远程缺血预处理(手臂的短暂性脑缺血和再灌注)能否提高接受冠状动脉旁路移植术(CABG)手术患者的临床疗效是不知道的。研究人员在一项随机试验中研究了这个问题。研究人员进行了一项多中心,假对照试验,涉及的参与者为使用血液心脏停搏正在接受体外循环CABG(有或无瓣膜手术)并处于手术风险增加的成年患者。麻醉诱导后和手术切口之前,患者被随机分配到接受远端缺血预处理(在上臂进行标准血压计4个5分钟的舒张和收缩

JACC:CABG术前血糖控制不良会出现不良预后

1型糖尿病(T1DM)患者发生心血管事件的风险很高。本研究旨在研究1型糖尿病患者CABG术前血糖控制不良是否会增加长期全因死亡及严重不良心血管事件(MACE)风险。 研究人员收纳了来自瑞典糖尿病研究注册中心的764名1型糖尿病患者。在平均4.7年的随访中,334名(44%)患者死亡或发生MACE事件(发病率:82/1000人/年)。调整多变量后,与对照组(HbA1c>7.0%)相比,1型糖尿病患

JACC:PCI和CABG治疗慢性肾脏疾病,长期和短期结果有差异

经皮冠状动脉介入治疗(PCI) vs 冠状动脉旁路移植术(CABG)的随机试验通常排除了患有慢性肾脏病(CKD)的患者。该研究的目的是评估CKD患者进行PCI vs CABG的结果。在纽约,该研究的参与者包括那些使用依维莫司洗脱支架接受PCI的CKD患者,以及倾向得分匹配的那些接受隔离CABG治疗多支冠状动脉病变的患者。主要研究终点为全因死亡率。次要终点是心肌梗死(MI),卒中和再次血运重建。在1

JACC:与PCI相比,CABG能够更大幅度的降低心梗有关的死亡率

在随机试验在,比较冠状动脉旁路移植术(CABG)和经皮冠状动脉介入治疗(PCI)的具体死因没有可用数据。

美国胸外科学会(AATS)首届国际冠脉外科大会撷英

         陈鑫教授 美国胸外科学会(AATS)首届国际冠脉外科大会(International coronarycongress,ICC)于2015年8月21~23日在纽约召开。本次大会由美国西奈山贝斯以色列医院普斯卡什(JohnPuskas)博士和英国牛津大学塔格特(David Tagga

JACC:T1DM患者CABG前血糖控制不佳会增加术后死亡或心血管事件的长期风险

1型糖尿病患者(T1DM)有很高的心血管事件发生的风险。    这项研究的目的是探讨术前血红蛋白A1c(HbA1c)水平能否预测冠状动脉旁路移植术(CABG)后心血管或死亡事件。    这是一个全国性的,以人口为基础的观察性队列研究,这些患者是在瑞典1997年至2012年间所有的初次接受单独的非紧急CABG的T1DM患者,患者信息来自于瑞

Baidu
map
Baidu
map
Baidu
map